Sam Chun Dang Pharm. Co., Ltd
000250
Rangering i aksjer
#4333
Sam Chun Dang Pharm Co., Ltd. is a pharmaceutical company that develops and... Sam Chun Dang Pharm Co., Ltd. is a pharmaceutical company that develops and produces a wide variety of medications. Its product range features antibiotics, treatments for cardiovascular and respiratory conditions, drugs for the digestive system and ophthalmic use, as well as anti-inflammatory agents. The company was founded on December 29, 1943, and its main operations are based in Hwaseong-si, South Korea.
Aksjekurs
$152.58
Markedsverdi
$3.57B
Endring (1 dag)
3.84%
Endring (1 år)
6.02%
Land
KR
Handel Sam Chun Dang Pharm. Co., Ltd (000250)
Kategori
Healthcare
P/S-forhold for Sam Chun Dang Pharm. Co., Ltd (000250)
P/S-forhold per October 2026 TTM: 18.06
Ifølge Sam Chun Dang Pharm. Co., Ltd sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/S-forhold (TTM) 18.06. Ved slutten av 2024 hadde selskapet et P/S-forhold på 16.20.
P/S-historikk for Sam Chun Dang Pharm. Co., Ltd fra 2012 til 2026
P/S-forhold ved hvert års slutt
| År | P/S-forhold | Endre |
|---|---|---|
| 2026 (TTM) | 18.06 | -23.25% |
| 2025 | 23.53 | 45.20% |
| 2024 | 16.20 | 74.25% |
| 2023 | 9.30 | 74.40% |
| 2022 | 5.33 | -6.76% |
| 2021 | 5.72 | -46.35% |
| 2020 | 10.66 | 161.04% |
| 2019 | 4.08 | -16.96% |
| 2018 | 4.92 | 100.67% |
| 2017 | 2.45 | 47.77% |
| 2016 | 1.66 | 16.95% |
| 2015 | 1.42 | -16.93% |
| 2014 | 1.71 | 99.22% |
| 2013 | 0.86 | 22.72% |
| 2012 | 0.70 | 0.00% |
P/S-forhold for lignende selskaper eller konkurrenter
| Selskap | P/S-forhold | Forskjell i P/S-forhold | Land |
|---|---|---|---|
| 11.07 | -38.69% |
US
|
|
| 5.13 | -71.60% |
SE
|
|
| 3.12 | -82.71% |
FR
|
|
| 4.01 | -77.80% |
IT
|
|
| 15.13 | -16.22% |
US
|
